nodes	percent_of_prediction	percent_of_DWPC	metapath
Naratriptan—HTR1D—Bromocriptine—type 2 diabetes mellitus	0.203	0.391	CbGbCtD
Naratriptan—HTR1B—Bromocriptine—type 2 diabetes mellitus	0.195	0.375	CbGbCtD
Naratriptan—HTR1A—Bromocriptine—type 2 diabetes mellitus	0.122	0.235	CbGbCtD
Naratriptan—HTR1B—artery—type 2 diabetes mellitus	0.0014	0.158	CbGeAlD
Naratriptan—HTR1D—artery—type 2 diabetes mellitus	0.00136	0.153	CbGeAlD
Naratriptan—Almotriptan—CYP2E1—type 2 diabetes mellitus	0.00105	0.326	CrCbGaD
Naratriptan—MAOA—nerve—type 2 diabetes mellitus	0.00102	0.116	CbGeAlD
Naratriptan—Almotriptan—CYP1A2—type 2 diabetes mellitus	0.000996	0.31	CrCbGaD
Naratriptan—Almotriptan—CYP3A4—type 2 diabetes mellitus	0.00066	0.205	CrCbGaD
Naratriptan—Eletriptan—CYP3A4—type 2 diabetes mellitus	0.000514	0.16	CrCbGaD
Naratriptan—MAOA—islet of Langerhans—type 2 diabetes mellitus	0.000496	0.056	CbGeAlD
Naratriptan—HTR1B—cardiovascular system—type 2 diabetes mellitus	0.000487	0.055	CbGeAlD
Naratriptan—HTR1D—cardiovascular system—type 2 diabetes mellitus	0.000471	0.0532	CbGeAlD
Naratriptan—HTR1D—kidney—type 2 diabetes mellitus	0.000461	0.0521	CbGeAlD
Naratriptan—MAOA—retina—type 2 diabetes mellitus	0.000424	0.0479	CbGeAlD
Naratriptan—MAOA—nephron tubule—type 2 diabetes mellitus	0.0004	0.0451	CbGeAlD
Naratriptan—HTR1A—cardiovascular system—type 2 diabetes mellitus	0.000393	0.0444	CbGeAlD
Naratriptan—MAOA—cardiovascular system—type 2 diabetes mellitus	0.000359	0.0405	CbGeAlD
Naratriptan—MAOA—kidney—type 2 diabetes mellitus	0.000351	0.0397	CbGeAlD
Naratriptan—MAOA—pancreas—type 2 diabetes mellitus	0.000349	0.0394	CbGeAlD
Naratriptan—MAOA—cortex of kidney—type 2 diabetes mellitus	0.000342	0.0386	CbGeAlD
Naratriptan—MAOA—adipose tissue—type 2 diabetes mellitus	0.000316	0.0357	CbGeAlD
Naratriptan—MAOA—liver—type 2 diabetes mellitus	0.000222	0.0251	CbGeAlD
Naratriptan—Urticaria—Glyburide—type 2 diabetes mellitus	0.000187	0.000557	CcSEcCtD
Naratriptan—Skin disorder—Orlistat—type 2 diabetes mellitus	0.000187	0.000555	CcSEcCtD
Naratriptan—Hyperhidrosis—Orlistat—type 2 diabetes mellitus	0.000186	0.000553	CcSEcCtD
Naratriptan—Muscle spasms—Losartan—type 2 diabetes mellitus	0.000185	0.000551	CcSEcCtD
Naratriptan—Asthenia—Bromocriptine—type 2 diabetes mellitus	0.000185	0.00055	CcSEcCtD
Naratriptan—Myalgia—Metformin—type 2 diabetes mellitus	0.000185	0.00055	CcSEcCtD
Naratriptan—Malaise—Irbesartan—type 2 diabetes mellitus	0.000185	0.000549	CcSEcCtD
Naratriptan—Vertigo—Irbesartan—type 2 diabetes mellitus	0.000184	0.000547	CcSEcCtD
Naratriptan—Headache—Pioglitazone—type 2 diabetes mellitus	0.000184	0.000547	CcSEcCtD
Naratriptan—Syncope—Irbesartan—type 2 diabetes mellitus	0.000184	0.000546	CcSEcCtD
Naratriptan—Gastrointestinal disorder—Gliclazide—type 2 diabetes mellitus	0.000183	0.000544	CcSEcCtD
Naratriptan—Discomfort—Metformin—type 2 diabetes mellitus	0.000183	0.000543	CcSEcCtD
Naratriptan—Fatigue—Gliclazide—type 2 diabetes mellitus	0.000183	0.000543	CcSEcCtD
Naratriptan—Nausea—Glipizide—type 2 diabetes mellitus	0.000182	0.000541	CcSEcCtD
Naratriptan—Vomiting—Glimepiride—type 2 diabetes mellitus	0.000182	0.000541	CcSEcCtD
Naratriptan—Hypotension—Valsartan—type 2 diabetes mellitus	0.000182	0.000541	CcSEcCtD
Naratriptan—Vision blurred—Losartan—type 2 diabetes mellitus	0.000182	0.00054	CcSEcCtD
Naratriptan—Vomiting—Sitagliptin—type 2 diabetes mellitus	0.000181	0.000539	CcSEcCtD
Naratriptan—Pain—Gliclazide—type 2 diabetes mellitus	0.000181	0.000538	CcSEcCtD
Naratriptan—Constipation—Gliclazide—type 2 diabetes mellitus	0.000181	0.000538	CcSEcCtD
Naratriptan—Tremor—Losartan—type 2 diabetes mellitus	0.000181	0.000537	CcSEcCtD
Naratriptan—Rash—Glimepiride—type 2 diabetes mellitus	0.00018	0.000536	CcSEcCtD
Naratriptan—Dermatitis—Glimepiride—type 2 diabetes mellitus	0.00018	0.000536	CcSEcCtD
Naratriptan—Loss of consciousness—Irbesartan—type 2 diabetes mellitus	0.00018	0.000535	CcSEcCtD
Naratriptan—Rash—Sitagliptin—type 2 diabetes mellitus	0.00018	0.000534	CcSEcCtD
Naratriptan—Dermatitis—Sitagliptin—type 2 diabetes mellitus	0.00018	0.000534	CcSEcCtD
Naratriptan—Headache—Glimepiride—type 2 diabetes mellitus	0.000179	0.000533	CcSEcCtD
Naratriptan—Ill-defined disorder—Losartan—type 2 diabetes mellitus	0.000179	0.000532	CcSEcCtD
Naratriptan—Cough—Irbesartan—type 2 diabetes mellitus	0.000179	0.000532	CcSEcCtD
Naratriptan—Headache—Sitagliptin—type 2 diabetes mellitus	0.000179	0.000531	CcSEcCtD
Naratriptan—Anaemia—Losartan—type 2 diabetes mellitus	0.000178	0.00053	CcSEcCtD
Naratriptan—Musculoskeletal discomfort—Valsartan—type 2 diabetes mellitus	0.000177	0.000527	CcSEcCtD
Naratriptan—Agitation—Losartan—type 2 diabetes mellitus	0.000177	0.000527	CcSEcCtD
Naratriptan—Oedema—Metformin—type 2 diabetes mellitus	0.000177	0.000527	CcSEcCtD
Naratriptan—Tinnitus—Ramipril—type 2 diabetes mellitus	0.000177	0.000526	CcSEcCtD
Naratriptan—Diarrhoea—Bromocriptine—type 2 diabetes mellitus	0.000177	0.000525	CcSEcCtD
Naratriptan—Infection—Metformin—type 2 diabetes mellitus	0.000176	0.000523	CcSEcCtD
Naratriptan—Musculoskeletal discomfort—Orlistat—type 2 diabetes mellitus	0.000175	0.000521	CcSEcCtD
Naratriptan—Paraesthesia—Valsartan—type 2 diabetes mellitus	0.000175	0.000519	CcSEcCtD
Naratriptan—Feeling abnormal—Gliclazide—type 2 diabetes mellitus	0.000174	0.000519	CcSEcCtD
Naratriptan—Myalgia—Irbesartan—type 2 diabetes mellitus	0.000174	0.000519	CcSEcCtD
Naratriptan—Arthralgia—Irbesartan—type 2 diabetes mellitus	0.000174	0.000519	CcSEcCtD
Naratriptan—Shock—Metformin—type 2 diabetes mellitus	0.000174	0.000518	CcSEcCtD
Naratriptan—Malaise—Losartan—type 2 diabetes mellitus	0.000174	0.000517	CcSEcCtD
Naratriptan—Anxiety—Irbesartan—type 2 diabetes mellitus	0.000174	0.000517	CcSEcCtD
Naratriptan—Hypersensitivity—Glyburide—type 2 diabetes mellitus	0.000174	0.000517	CcSEcCtD
Naratriptan—Nervous system disorder—Metformin—type 2 diabetes mellitus	0.000174	0.000517	CcSEcCtD
Naratriptan—Thrombocytopenia—Metformin—type 2 diabetes mellitus	0.000173	0.000516	CcSEcCtD
Naratriptan—Dyspnoea—Valsartan—type 2 diabetes mellitus	0.000173	0.000516	CcSEcCtD
Naratriptan—Vertigo—Losartan—type 2 diabetes mellitus	0.000173	0.000515	CcSEcCtD
Naratriptan—Somnolence—Valsartan—type 2 diabetes mellitus	0.000173	0.000514	CcSEcCtD
Naratriptan—Syncope—Losartan—type 2 diabetes mellitus	0.000173	0.000514	CcSEcCtD
Naratriptan—Paraesthesia—Orlistat—type 2 diabetes mellitus	0.000173	0.000513	CcSEcCtD
Naratriptan—Discomfort—Irbesartan—type 2 diabetes mellitus	0.000172	0.000512	CcSEcCtD
Naratriptan—Skin disorder—Metformin—type 2 diabetes mellitus	0.000172	0.000512	CcSEcCtD
Naratriptan—Immune system disorder—Ramipril—type 2 diabetes mellitus	0.000172	0.00051	CcSEcCtD
Naratriptan—Hyperhidrosis—Metformin—type 2 diabetes mellitus	0.000171	0.000509	CcSEcCtD
Naratriptan—Dizziness—Bromocriptine—type 2 diabetes mellitus	0.000171	0.000507	CcSEcCtD
Naratriptan—Dry mouth—Irbesartan—type 2 diabetes mellitus	0.000171	0.000507	CcSEcCtD
Naratriptan—Palpitations—Losartan—type 2 diabetes mellitus	0.00017	0.000507	CcSEcCtD
Naratriptan—Nausea—Glimepiride—type 2 diabetes mellitus	0.00017	0.000505	CcSEcCtD
Naratriptan—Arrhythmia—Ramipril—type 2 diabetes mellitus	0.00017	0.000504	CcSEcCtD
Naratriptan—Loss of consciousness—Losartan—type 2 diabetes mellitus	0.000169	0.000504	CcSEcCtD
Naratriptan—Nausea—Sitagliptin—type 2 diabetes mellitus	0.000169	0.000503	CcSEcCtD
Naratriptan—Asthenia—Glyburide—type 2 diabetes mellitus	0.000169	0.000503	CcSEcCtD
Naratriptan—Cough—Losartan—type 2 diabetes mellitus	0.000168	0.0005	CcSEcCtD
Naratriptan—Urticaria—Gliclazide—type 2 diabetes mellitus	0.000168	0.0005	CcSEcCtD
Naratriptan—Gastrointestinal disorder—Valsartan—type 2 diabetes mellitus	0.000168	0.000499	CcSEcCtD
Naratriptan—Alopecia—Ramipril—type 2 diabetes mellitus	0.000168	0.000499	CcSEcCtD
Naratriptan—Fatigue—Valsartan—type 2 diabetes mellitus	0.000168	0.000499	CcSEcCtD
Naratriptan—Body temperature increased—Gliclazide—type 2 diabetes mellitus	0.000167	0.000498	CcSEcCtD
Naratriptan—Anaphylactic shock—Irbesartan—type 2 diabetes mellitus	0.000167	0.000497	CcSEcCtD
Naratriptan—Oedema—Irbesartan—type 2 diabetes mellitus	0.000167	0.000497	CcSEcCtD
Naratriptan—Pruritus—Glyburide—type 2 diabetes mellitus	0.000167	0.000496	CcSEcCtD
Naratriptan—Constipation—Valsartan—type 2 diabetes mellitus	0.000166	0.000495	CcSEcCtD
Naratriptan—Infection—Irbesartan—type 2 diabetes mellitus	0.000166	0.000494	CcSEcCtD
Naratriptan—Gastrointestinal disorder—Orlistat—type 2 diabetes mellitus	0.000166	0.000494	CcSEcCtD
Naratriptan—Fatigue—Orlistat—type 2 diabetes mellitus	0.000166	0.000493	CcSEcCtD
Naratriptan—Hypotension—Metformin—type 2 diabetes mellitus	0.000166	0.000492	CcSEcCtD
Naratriptan—Erythema—Ramipril—type 2 diabetes mellitus	0.000165	0.000492	CcSEcCtD
Naratriptan—Shock—Irbesartan—type 2 diabetes mellitus	0.000164	0.000489	CcSEcCtD
Naratriptan—Pain—Orlistat—type 2 diabetes mellitus	0.000164	0.000489	CcSEcCtD
Naratriptan—Arthralgia—Losartan—type 2 diabetes mellitus	0.000164	0.000488	CcSEcCtD
Naratriptan—Myalgia—Losartan—type 2 diabetes mellitus	0.000164	0.000488	CcSEcCtD
Naratriptan—Vomiting—Bromocriptine—type 2 diabetes mellitus	0.000164	0.000488	CcSEcCtD
Naratriptan—Nervous system disorder—Irbesartan—type 2 diabetes mellitus	0.000164	0.000488	CcSEcCtD
Naratriptan—Thrombocytopenia—Irbesartan—type 2 diabetes mellitus	0.000164	0.000487	CcSEcCtD
Naratriptan—Anxiety—Losartan—type 2 diabetes mellitus	0.000164	0.000486	CcSEcCtD
Naratriptan—Rash—Bromocriptine—type 2 diabetes mellitus	0.000163	0.000484	CcSEcCtD
Naratriptan—Dermatitis—Bromocriptine—type 2 diabetes mellitus	0.000162	0.000483	CcSEcCtD
Naratriptan—Skin disorder—Irbesartan—type 2 diabetes mellitus	0.000162	0.000483	CcSEcCtD
Naratriptan—Discomfort—Losartan—type 2 diabetes mellitus	0.000162	0.000482	CcSEcCtD
Naratriptan—Hyperhidrosis—Irbesartan—type 2 diabetes mellitus	0.000162	0.000481	CcSEcCtD
Naratriptan—Headache—Bromocriptine—type 2 diabetes mellitus	0.000162	0.000481	CcSEcCtD
Naratriptan—Musculoskeletal discomfort—Metformin—type 2 diabetes mellitus	0.000161	0.00048	CcSEcCtD
Naratriptan—Diarrhoea—Glyburide—type 2 diabetes mellitus	0.000161	0.00048	CcSEcCtD
Naratriptan—Dry mouth—Losartan—type 2 diabetes mellitus	0.000161	0.000477	CcSEcCtD
Naratriptan—Paraesthesia—Metformin—type 2 diabetes mellitus	0.000159	0.000473	CcSEcCtD
Naratriptan—Muscle spasms—Ramipril—type 2 diabetes mellitus	0.000159	0.000473	CcSEcCtD
Naratriptan—Confusional state—Losartan—type 2 diabetes mellitus	0.000159	0.000472	CcSEcCtD
Naratriptan—Feeling abnormal—Orlistat—type 2 diabetes mellitus	0.000158	0.000471	CcSEcCtD
Naratriptan—Dyspnoea—Metformin—type 2 diabetes mellitus	0.000158	0.00047	CcSEcCtD
Naratriptan—Somnolence—Metformin—type 2 diabetes mellitus	0.000157	0.000468	CcSEcCtD
Naratriptan—Oedema—Losartan—type 2 diabetes mellitus	0.000157	0.000468	CcSEcCtD
Naratriptan—Anaphylactic shock—Losartan—type 2 diabetes mellitus	0.000157	0.000468	CcSEcCtD
Naratriptan—Infection—Losartan—type 2 diabetes mellitus	0.000156	0.000465	CcSEcCtD
Naratriptan—Hypotension—Irbesartan—type 2 diabetes mellitus	0.000156	0.000465	CcSEcCtD
Naratriptan—Hypersensitivity—Gliclazide—type 2 diabetes mellitus	0.000156	0.000464	CcSEcCtD
Naratriptan—Tremor—Ramipril—type 2 diabetes mellitus	0.000155	0.000461	CcSEcCtD
Naratriptan—Shock—Losartan—type 2 diabetes mellitus	0.000155	0.00046	CcSEcCtD
Naratriptan—Urticaria—Valsartan—type 2 diabetes mellitus	0.000155	0.00046	CcSEcCtD
Naratriptan—Nervous system disorder—Losartan—type 2 diabetes mellitus	0.000154	0.000459	CcSEcCtD
Naratriptan—Thrombocytopenia—Losartan—type 2 diabetes mellitus	0.000154	0.000458	CcSEcCtD
Naratriptan—Ill-defined disorder—Ramipril—type 2 diabetes mellitus	0.000153	0.000456	CcSEcCtD
Naratriptan—Nausea—Bromocriptine—type 2 diabetes mellitus	0.000153	0.000456	CcSEcCtD
Naratriptan—Gastrointestinal disorder—Metformin—type 2 diabetes mellitus	0.000153	0.000455	CcSEcCtD
Naratriptan—Fatigue—Metformin—type 2 diabetes mellitus	0.000153	0.000454	CcSEcCtD
Naratriptan—Urticaria—Orlistat—type 2 diabetes mellitus	0.000153	0.000454	CcSEcCtD
Naratriptan—Musculoskeletal discomfort—Irbesartan—type 2 diabetes mellitus	0.000152	0.000453	CcSEcCtD
Naratriptan—Hyperhidrosis—Losartan—type 2 diabetes mellitus	0.000152	0.000452	CcSEcCtD
Naratriptan—Body temperature increased—Orlistat—type 2 diabetes mellitus	0.000152	0.000452	CcSEcCtD
Naratriptan—Asthenia—Gliclazide—type 2 diabetes mellitus	0.000152	0.000452	CcSEcCtD
Naratriptan—Agitation—Ramipril—type 2 diabetes mellitus	0.000152	0.000452	CcSEcCtD
Naratriptan—Constipation—Metformin—type 2 diabetes mellitus	0.000152	0.00045	CcSEcCtD
Naratriptan—Paraesthesia—Irbesartan—type 2 diabetes mellitus	0.00015	0.000446	CcSEcCtD
Naratriptan—Vomiting—Glyburide—type 2 diabetes mellitus	0.00015	0.000446	CcSEcCtD
Naratriptan—Pruritus—Gliclazide—type 2 diabetes mellitus	0.00015	0.000445	CcSEcCtD
Naratriptan—Malaise—Ramipril—type 2 diabetes mellitus	0.000149	0.000443	CcSEcCtD
Naratriptan—Dyspnoea—Irbesartan—type 2 diabetes mellitus	0.000149	0.000443	CcSEcCtD
Naratriptan—Rash—Glyburide—type 2 diabetes mellitus	0.000149	0.000442	CcSEcCtD
Naratriptan—Somnolence—Irbesartan—type 2 diabetes mellitus	0.000149	0.000442	CcSEcCtD
Naratriptan—Dermatitis—Glyburide—type 2 diabetes mellitus	0.000149	0.000442	CcSEcCtD
Naratriptan—Vertigo—Ramipril—type 2 diabetes mellitus	0.000149	0.000442	CcSEcCtD
Naratriptan—Syncope—Ramipril—type 2 diabetes mellitus	0.000148	0.000441	CcSEcCtD
Naratriptan—Headache—Glyburide—type 2 diabetes mellitus	0.000148	0.000439	CcSEcCtD
Naratriptan—Hypotension—Losartan—type 2 diabetes mellitus	0.000147	0.000437	CcSEcCtD
Naratriptan—Palpitations—Ramipril—type 2 diabetes mellitus	0.000146	0.000434	CcSEcCtD
Naratriptan—Feeling abnormal—Metformin—type 2 diabetes mellitus	0.000146	0.000434	CcSEcCtD
Naratriptan—Loss of consciousness—Ramipril—type 2 diabetes mellitus	0.000145	0.000432	CcSEcCtD
Naratriptan—Diarrhoea—Gliclazide—type 2 diabetes mellitus	0.000145	0.000431	CcSEcCtD
Naratriptan—Gastrointestinal disorder—Irbesartan—type 2 diabetes mellitus	0.000144	0.000429	CcSEcCtD
Naratriptan—Cough—Ramipril—type 2 diabetes mellitus	0.000144	0.000429	CcSEcCtD
Naratriptan—Fatigue—Irbesartan—type 2 diabetes mellitus	0.000144	0.000429	CcSEcCtD
Naratriptan—Musculoskeletal discomfort—Losartan—type 2 diabetes mellitus	0.000143	0.000426	CcSEcCtD
Naratriptan—Hypersensitivity—Valsartan—type 2 diabetes mellitus	0.000143	0.000426	CcSEcCtD
Naratriptan—Convulsion—Ramipril—type 2 diabetes mellitus	0.000143	0.000426	CcSEcCtD
Naratriptan—Pain—Irbesartan—type 2 diabetes mellitus	0.000143	0.000425	CcSEcCtD
Naratriptan—Constipation—Irbesartan—type 2 diabetes mellitus	0.000143	0.000425	CcSEcCtD
Naratriptan—Hypersensitivity—Orlistat—type 2 diabetes mellitus	0.000142	0.000421	CcSEcCtD
Naratriptan—Paraesthesia—Losartan—type 2 diabetes mellitus	0.000141	0.00042	CcSEcCtD
Naratriptan—Urticaria—Metformin—type 2 diabetes mellitus	0.000141	0.000419	CcSEcCtD
Naratriptan—Myalgia—Ramipril—type 2 diabetes mellitus	0.000141	0.000418	CcSEcCtD
Naratriptan—Arthralgia—Ramipril—type 2 diabetes mellitus	0.000141	0.000418	CcSEcCtD
Naratriptan—Dyspnoea—Losartan—type 2 diabetes mellitus	0.00014	0.000417	CcSEcCtD
Naratriptan—Anxiety—Ramipril—type 2 diabetes mellitus	0.00014	0.000417	CcSEcCtD
Naratriptan—Nausea—Glyburide—type 2 diabetes mellitus	0.00014	0.000417	CcSEcCtD
Naratriptan—Dizziness—Gliclazide—type 2 diabetes mellitus	0.00014	0.000416	CcSEcCtD
Naratriptan—Somnolence—Losartan—type 2 diabetes mellitus	0.00014	0.000416	CcSEcCtD
Naratriptan—Asthenia—Valsartan—type 2 diabetes mellitus	0.00014	0.000415	CcSEcCtD
Naratriptan—Discomfort—Ramipril—type 2 diabetes mellitus	0.000139	0.000413	CcSEcCtD
Naratriptan—Asthenia—Orlistat—type 2 diabetes mellitus	0.000138	0.00041	CcSEcCtD
Naratriptan—Feeling abnormal—Irbesartan—type 2 diabetes mellitus	0.000138	0.00041	CcSEcCtD
Naratriptan—Pruritus—Valsartan—type 2 diabetes mellitus	0.000138	0.000409	CcSEcCtD
Naratriptan—Dry mouth—Ramipril—type 2 diabetes mellitus	0.000138	0.000409	CcSEcCtD
Naratriptan—Confusional state—Ramipril—type 2 diabetes mellitus	0.000136	0.000405	CcSEcCtD
Naratriptan—Pruritus—Orlistat—type 2 diabetes mellitus	0.000136	0.000404	CcSEcCtD
Naratriptan—Fatigue—Losartan—type 2 diabetes mellitus	0.000136	0.000403	CcSEcCtD
Naratriptan—Anaphylactic shock—Ramipril—type 2 diabetes mellitus	0.000135	0.000401	CcSEcCtD
Naratriptan—Oedema—Ramipril—type 2 diabetes mellitus	0.000135	0.000401	CcSEcCtD
Naratriptan—Vomiting—Gliclazide—type 2 diabetes mellitus	0.000135	0.0004	CcSEcCtD
Naratriptan—Constipation—Losartan—type 2 diabetes mellitus	0.000135	0.0004	CcSEcCtD
Naratriptan—Pain—Losartan—type 2 diabetes mellitus	0.000135	0.0004	CcSEcCtD
Naratriptan—Rash—Gliclazide—type 2 diabetes mellitus	0.000134	0.000397	CcSEcCtD
Naratriptan—Dermatitis—Gliclazide—type 2 diabetes mellitus	0.000133	0.000397	CcSEcCtD
Naratriptan—Diarrhoea—Valsartan—type 2 diabetes mellitus	0.000133	0.000396	CcSEcCtD
Naratriptan—Urticaria—Irbesartan—type 2 diabetes mellitus	0.000133	0.000395	CcSEcCtD
Naratriptan—Shock—Ramipril—type 2 diabetes mellitus	0.000133	0.000395	CcSEcCtD
Naratriptan—Headache—Gliclazide—type 2 diabetes mellitus	0.000133	0.000394	CcSEcCtD
Naratriptan—Nervous system disorder—Ramipril—type 2 diabetes mellitus	0.000132	0.000393	CcSEcCtD
Naratriptan—Body temperature increased—Irbesartan—type 2 diabetes mellitus	0.000132	0.000393	CcSEcCtD
Naratriptan—Thrombocytopenia—Ramipril—type 2 diabetes mellitus	0.000132	0.000393	CcSEcCtD
Naratriptan—Diarrhoea—Orlistat—type 2 diabetes mellitus	0.000132	0.000391	CcSEcCtD
Naratriptan—Skin disorder—Ramipril—type 2 diabetes mellitus	0.000131	0.00039	CcSEcCtD
Naratriptan—Hyperhidrosis—Ramipril—type 2 diabetes mellitus	0.00013	0.000388	CcSEcCtD
Naratriptan—Feeling abnormal—Losartan—type 2 diabetes mellitus	0.00013	0.000386	CcSEcCtD
Naratriptan—Dizziness—Valsartan—type 2 diabetes mellitus	0.000129	0.000383	CcSEcCtD
Naratriptan—Dizziness—Orlistat—type 2 diabetes mellitus	0.000127	0.000378	CcSEcCtD
Naratriptan—Asthenia—Metformin—type 2 diabetes mellitus	0.000127	0.000378	CcSEcCtD
Naratriptan—Hypotension—Ramipril—type 2 diabetes mellitus	0.000126	0.000375	CcSEcCtD
Naratriptan—Nausea—Gliclazide—type 2 diabetes mellitus	0.000126	0.000374	CcSEcCtD
Naratriptan—Pruritus—Metformin—type 2 diabetes mellitus	0.000125	0.000373	CcSEcCtD
Naratriptan—Urticaria—Losartan—type 2 diabetes mellitus	0.000125	0.000372	CcSEcCtD
Naratriptan—Body temperature increased—Losartan—type 2 diabetes mellitus	0.000124	0.00037	CcSEcCtD
Naratriptan—Vomiting—Valsartan—type 2 diabetes mellitus	0.000124	0.000368	CcSEcCtD
Naratriptan—Hypersensitivity—Irbesartan—type 2 diabetes mellitus	0.000123	0.000366	CcSEcCtD
Naratriptan—Musculoskeletal discomfort—Ramipril—type 2 diabetes mellitus	0.000123	0.000366	CcSEcCtD
Naratriptan—Rash—Valsartan—type 2 diabetes mellitus	0.000123	0.000365	CcSEcCtD
Naratriptan—Dermatitis—Valsartan—type 2 diabetes mellitus	0.000123	0.000364	CcSEcCtD
Naratriptan—Vomiting—Orlistat—type 2 diabetes mellitus	0.000122	0.000363	CcSEcCtD
Naratriptan—Headache—Valsartan—type 2 diabetes mellitus	0.000122	0.000362	CcSEcCtD
Naratriptan—Diarrhoea—Metformin—type 2 diabetes mellitus	0.000121	0.00036	CcSEcCtD
Naratriptan—Rash—Orlistat—type 2 diabetes mellitus	0.000121	0.00036	CcSEcCtD
Naratriptan—Paraesthesia—Ramipril—type 2 diabetes mellitus	0.000121	0.00036	CcSEcCtD
Naratriptan—Dermatitis—Orlistat—type 2 diabetes mellitus	0.000121	0.00036	CcSEcCtD
Naratriptan—Headache—Orlistat—type 2 diabetes mellitus	0.00012	0.000358	CcSEcCtD
Naratriptan—Dyspnoea—Ramipril—type 2 diabetes mellitus	0.00012	0.000358	CcSEcCtD
Naratriptan—Asthenia—Irbesartan—type 2 diabetes mellitus	0.00012	0.000357	CcSEcCtD
Naratriptan—Somnolence—Ramipril—type 2 diabetes mellitus	0.00012	0.000357	CcSEcCtD
Naratriptan—Pruritus—Irbesartan—type 2 diabetes mellitus	0.000118	0.000352	CcSEcCtD
Naratriptan—Dizziness—Metformin—type 2 diabetes mellitus	0.000117	0.000348	CcSEcCtD
Naratriptan—Gastrointestinal disorder—Ramipril—type 2 diabetes mellitus	0.000116	0.000346	CcSEcCtD
Naratriptan—Fatigue—Ramipril—type 2 diabetes mellitus	0.000116	0.000346	CcSEcCtD
Naratriptan—Hypersensitivity—Losartan—type 2 diabetes mellitus	0.000116	0.000345	CcSEcCtD
Naratriptan—Nausea—Valsartan—type 2 diabetes mellitus	0.000116	0.000344	CcSEcCtD
Naratriptan—Constipation—Ramipril—type 2 diabetes mellitus	0.000115	0.000343	CcSEcCtD
Naratriptan—Diarrhoea—Irbesartan—type 2 diabetes mellitus	0.000114	0.00034	CcSEcCtD
Naratriptan—Nausea—Orlistat—type 2 diabetes mellitus	0.000114	0.00034	CcSEcCtD
Naratriptan—Asthenia—Losartan—type 2 diabetes mellitus	0.000113	0.000336	CcSEcCtD
Naratriptan—Vomiting—Metformin—type 2 diabetes mellitus	0.000113	0.000335	CcSEcCtD
Naratriptan—Rash—Metformin—type 2 diabetes mellitus	0.000112	0.000332	CcSEcCtD
Naratriptan—Dermatitis—Metformin—type 2 diabetes mellitus	0.000112	0.000332	CcSEcCtD
Naratriptan—Pruritus—Losartan—type 2 diabetes mellitus	0.000111	0.000331	CcSEcCtD
Naratriptan—Feeling abnormal—Ramipril—type 2 diabetes mellitus	0.000111	0.000331	CcSEcCtD
Naratriptan—Headache—Metformin—type 2 diabetes mellitus	0.000111	0.00033	CcSEcCtD
Naratriptan—Dizziness—Irbesartan—type 2 diabetes mellitus	0.000111	0.000329	CcSEcCtD
Naratriptan—Diarrhoea—Losartan—type 2 diabetes mellitus	0.000108	0.00032	CcSEcCtD
Naratriptan—Urticaria—Ramipril—type 2 diabetes mellitus	0.000107	0.000319	CcSEcCtD
Naratriptan—Body temperature increased—Ramipril—type 2 diabetes mellitus	0.000107	0.000317	CcSEcCtD
Naratriptan—Vomiting—Irbesartan—type 2 diabetes mellitus	0.000106	0.000316	CcSEcCtD
Naratriptan—Rash—Irbesartan—type 2 diabetes mellitus	0.000105	0.000313	CcSEcCtD
Naratriptan—Dermatitis—Irbesartan—type 2 diabetes mellitus	0.000105	0.000313	CcSEcCtD
Naratriptan—Nausea—Metformin—type 2 diabetes mellitus	0.000105	0.000313	CcSEcCtD
Naratriptan—Headache—Irbesartan—type 2 diabetes mellitus	0.000105	0.000311	CcSEcCtD
Naratriptan—Dizziness—Losartan—type 2 diabetes mellitus	0.000104	0.000309	CcSEcCtD
Naratriptan—Vomiting—Losartan—type 2 diabetes mellitus	0.0001	0.000297	CcSEcCtD
Naratriptan—Hypersensitivity—Ramipril—type 2 diabetes mellitus	9.94e-05	0.000296	CcSEcCtD
Naratriptan—Nausea—Irbesartan—type 2 diabetes mellitus	9.93e-05	0.000295	CcSEcCtD
Naratriptan—Rash—Losartan—type 2 diabetes mellitus	9.92e-05	0.000295	CcSEcCtD
Naratriptan—Dermatitis—Losartan—type 2 diabetes mellitus	9.91e-05	0.000295	CcSEcCtD
Naratriptan—Headache—Losartan—type 2 diabetes mellitus	9.86e-05	0.000293	CcSEcCtD
Naratriptan—Asthenia—Ramipril—type 2 diabetes mellitus	9.68e-05	0.000288	CcSEcCtD
Naratriptan—Pruritus—Ramipril—type 2 diabetes mellitus	9.55e-05	0.000284	CcSEcCtD
Naratriptan—Nausea—Losartan—type 2 diabetes mellitus	9.35e-05	0.000278	CcSEcCtD
Naratriptan—Diarrhoea—Ramipril—type 2 diabetes mellitus	9.23e-05	0.000274	CcSEcCtD
Naratriptan—Dizziness—Ramipril—type 2 diabetes mellitus	8.92e-05	0.000265	CcSEcCtD
Naratriptan—Vomiting—Ramipril—type 2 diabetes mellitus	8.58e-05	0.000255	CcSEcCtD
Naratriptan—Rash—Ramipril—type 2 diabetes mellitus	8.51e-05	0.000253	CcSEcCtD
Naratriptan—Dermatitis—Ramipril—type 2 diabetes mellitus	8.5e-05	0.000253	CcSEcCtD
Naratriptan—Headache—Ramipril—type 2 diabetes mellitus	8.45e-05	0.000251	CcSEcCtD
Naratriptan—Nausea—Ramipril—type 2 diabetes mellitus	8.01e-05	0.000238	CcSEcCtD
Naratriptan—HTR1A—GPCR downstream signaling—ADCY5—type 2 diabetes mellitus	2.81e-05	0.000213	CbGpPWpGaD
Naratriptan—MAOA—Metabolism—CYP3A4—type 2 diabetes mellitus	2.8e-05	0.000212	CbGpPWpGaD
Naratriptan—HTR1A—Signaling Pathways—CCKAR—type 2 diabetes mellitus	2.78e-05	0.000211	CbGpPWpGaD
Naratriptan—HTR1B—Signaling Pathways—CALCA—type 2 diabetes mellitus	2.78e-05	0.00021	CbGpPWpGaD
Naratriptan—HTR1F—Signaling Pathways—HIF1A—type 2 diabetes mellitus	2.77e-05	0.00021	CbGpPWpGaD
Naratriptan—HTR1F—Signaling Pathways—IRS2—type 2 diabetes mellitus	2.76e-05	0.000209	CbGpPWpGaD
Naratriptan—HTR1D—Signaling by GPCR—PRKCB—type 2 diabetes mellitus	2.76e-05	0.000209	CbGpPWpGaD
Naratriptan—HTR1F—Signaling Pathways—AGT—type 2 diabetes mellitus	2.76e-05	0.000209	CbGpPWpGaD
Naratriptan—MAOA—Metabolism—SLC2A4—type 2 diabetes mellitus	2.76e-05	0.000209	CbGpPWpGaD
Naratriptan—MAOA—Metabolism—GCG—type 2 diabetes mellitus	2.76e-05	0.000209	CbGpPWpGaD
Naratriptan—HTR1F—Signaling Pathways—CALM1—type 2 diabetes mellitus	2.71e-05	0.000205	CbGpPWpGaD
Naratriptan—HTR1F—Signaling Pathways—LEP—type 2 diabetes mellitus	2.7e-05	0.000205	CbGpPWpGaD
Naratriptan—HTR1F—Signaling Pathways—APOE—type 2 diabetes mellitus	2.7e-05	0.000205	CbGpPWpGaD
Naratriptan—HTR1B—Signaling by GPCR—PRKCB—type 2 diabetes mellitus	2.7e-05	0.000205	CbGpPWpGaD
Naratriptan—HTR1A—Signaling by GPCR—EDN1—type 2 diabetes mellitus	2.68e-05	0.000203	CbGpPWpGaD
Naratriptan—HTR1D—Signaling Pathways—TCF7L2—type 2 diabetes mellitus	2.67e-05	0.000202	CbGpPWpGaD
Naratriptan—HTR1F—Signaling Pathways—APOA1—type 2 diabetes mellitus	2.67e-05	0.000202	CbGpPWpGaD
Naratriptan—HTR1D—GPCR downstream signaling—AKT2—type 2 diabetes mellitus	2.66e-05	0.000201	CbGpPWpGaD
Naratriptan—HTR1A—GPCR downstream signaling—CCR5—type 2 diabetes mellitus	2.64e-05	0.0002	CbGpPWpGaD
Naratriptan—HTR1D—Signaling Pathways—PTPN1—type 2 diabetes mellitus	2.63e-05	0.000199	CbGpPWpGaD
Naratriptan—HTR1D—Signaling Pathways—GCG—type 2 diabetes mellitus	2.63e-05	0.000199	CbGpPWpGaD
Naratriptan—HTR1B—Signaling Pathways—TCF7L2—type 2 diabetes mellitus	2.62e-05	0.000198	CbGpPWpGaD
Naratriptan—HTR1B—GPCR downstream signaling—AKT2—type 2 diabetes mellitus	2.6e-05	0.000197	CbGpPWpGaD
Naratriptan—HTR1D—Signaling Pathways—RASGRP1—type 2 diabetes mellitus	2.58e-05	0.000196	CbGpPWpGaD
Naratriptan—HTR1A—GPCR downstream signaling—C3—type 2 diabetes mellitus	2.58e-05	0.000195	CbGpPWpGaD
Naratriptan—HTR1D—Signaling Pathways—NOTCH2—type 2 diabetes mellitus	2.58e-05	0.000195	CbGpPWpGaD
Naratriptan—HTR1B—Signaling Pathways—PTPN1—type 2 diabetes mellitus	2.57e-05	0.000195	CbGpPWpGaD
Naratriptan—HTR1B—Signaling Pathways—GCG—type 2 diabetes mellitus	2.57e-05	0.000195	CbGpPWpGaD
Naratriptan—HTR1A—Signaling by GPCR—ADCY5—type 2 diabetes mellitus	2.55e-05	0.000193	CbGpPWpGaD
Naratriptan—HTR1F—Signaling Pathways—PRKCB—type 2 diabetes mellitus	2.55e-05	0.000193	CbGpPWpGaD
Naratriptan—HTR1B—Signaling Pathways—RASGRP1—type 2 diabetes mellitus	2.53e-05	0.000192	CbGpPWpGaD
Naratriptan—HTR1B—Signaling Pathways—NOTCH2—type 2 diabetes mellitus	2.52e-05	0.000191	CbGpPWpGaD
Naratriptan—HTR1A—Signaling Pathways—ATP2A2—type 2 diabetes mellitus	2.52e-05	0.000191	CbGpPWpGaD
Naratriptan—HTR1A—Signaling Pathways—IAPP—type 2 diabetes mellitus	2.5e-05	0.00019	CbGpPWpGaD
Naratriptan—HTR1A—Signaling Pathways—INSR—type 2 diabetes mellitus	2.49e-05	0.000189	CbGpPWpGaD
Naratriptan—HTR1D—Signaling by GPCR—CCL2—type 2 diabetes mellitus	2.46e-05	0.000186	CbGpPWpGaD
Naratriptan—HTR1A—GPCR downstream signaling—AGT—type 2 diabetes mellitus	2.45e-05	0.000186	CbGpPWpGaD
Naratriptan—HTR1A—Signaling Pathways—TRPC6—type 2 diabetes mellitus	2.44e-05	0.000185	CbGpPWpGaD
Naratriptan—HTR1A—Signaling by GPCR—PPP2CA—type 2 diabetes mellitus	2.44e-05	0.000185	CbGpPWpGaD
Naratriptan—HTR1A—Signaling Pathways—AGTR2—type 2 diabetes mellitus	2.43e-05	0.000184	CbGpPWpGaD
Naratriptan—HTR1D—Signaling by GPCR—AKT2—type 2 diabetes mellitus	2.41e-05	0.000183	CbGpPWpGaD
Naratriptan—HTR1D—GPCR downstream signaling—PIK3R1—type 2 diabetes mellitus	2.41e-05	0.000183	CbGpPWpGaD
Naratriptan—HTR1F—Signaling Pathways—IRS1—type 2 diabetes mellitus	2.41e-05	0.000183	CbGpPWpGaD
Naratriptan—HTR1B—Signaling by GPCR—CCL2—type 2 diabetes mellitus	2.41e-05	0.000182	CbGpPWpGaD
Naratriptan—HTR1A—Signaling by GPCR—CCR5—type 2 diabetes mellitus	2.4e-05	0.000182	CbGpPWpGaD
Naratriptan—MAOA—Metabolism—PPARGC1A—type 2 diabetes mellitus	2.38e-05	0.00018	CbGpPWpGaD
Naratriptan—MAOA—Metabolism—GNB3—type 2 diabetes mellitus	2.38e-05	0.00018	CbGpPWpGaD
Naratriptan—MAOA—Metabolism—HMOX1—type 2 diabetes mellitus	2.36e-05	0.000179	CbGpPWpGaD
Naratriptan—HTR1B—Signaling by GPCR—AKT2—type 2 diabetes mellitus	2.36e-05	0.000179	CbGpPWpGaD
Naratriptan—HTR1B—GPCR downstream signaling—PIK3R1—type 2 diabetes mellitus	2.36e-05	0.000179	CbGpPWpGaD
Naratriptan—HTR1A—Signaling by GPCR—C3—type 2 diabetes mellitus	2.34e-05	0.000177	CbGpPWpGaD
Naratriptan—MAOA—Metabolism—CAT—type 2 diabetes mellitus	2.33e-05	0.000177	CbGpPWpGaD
Naratriptan—HTR1A—Signaling Pathways—EDNRB—type 2 diabetes mellitus	2.33e-05	0.000176	CbGpPWpGaD
Naratriptan—HTR1F—Signaling Pathways—INS—type 2 diabetes mellitus	2.31e-05	0.000175	CbGpPWpGaD
Naratriptan—HTR1D—Signaling Pathways—TGFBR2—type 2 diabetes mellitus	2.28e-05	0.000173	CbGpPWpGaD
Naratriptan—HTR1F—Signaling Pathways—CCL2—type 2 diabetes mellitus	2.27e-05	0.000172	CbGpPWpGaD
Naratriptan—HTR1A—GPCR downstream signaling—PRKCB—type 2 diabetes mellitus	2.27e-05	0.000172	CbGpPWpGaD
Naratriptan—MAOA—Metabolism—APOB—type 2 diabetes mellitus	2.27e-05	0.000172	CbGpPWpGaD
Naratriptan—HTR1D—Signaling Pathways—GNB3—type 2 diabetes mellitus	2.26e-05	0.000171	CbGpPWpGaD
Naratriptan—HTR1A—Signaling Pathways—PSMD6—type 2 diabetes mellitus	2.26e-05	0.000171	CbGpPWpGaD
Naratriptan—HTR1A—Signaling Pathways—HTR2C—type 2 diabetes mellitus	2.26e-05	0.000171	CbGpPWpGaD
Naratriptan—HTR1B—Signaling Pathways—TGFBR2—type 2 diabetes mellitus	2.24e-05	0.000169	CbGpPWpGaD
Naratriptan—HTR1D—Signaling Pathways—AVP—type 2 diabetes mellitus	2.23e-05	0.000169	CbGpPWpGaD
Naratriptan—HTR1D—Signaling Pathways—MMP3—type 2 diabetes mellitus	2.23e-05	0.000169	CbGpPWpGaD
Naratriptan—HTR1F—Signaling Pathways—IGF1—type 2 diabetes mellitus	2.23e-05	0.000169	CbGpPWpGaD
Naratriptan—HTR1F—Signaling Pathways—AKT2—type 2 diabetes mellitus	2.23e-05	0.000169	CbGpPWpGaD
Naratriptan—HTR1A—Signaling by GPCR—AGT—type 2 diabetes mellitus	2.23e-05	0.000169	CbGpPWpGaD
Naratriptan—HTR1D—Signaling Pathways—IGF2—type 2 diabetes mellitus	2.22e-05	0.000168	CbGpPWpGaD
Naratriptan—HTR1F—Signaling by GPCR—EGFR—type 2 diabetes mellitus	2.22e-05	0.000168	CbGpPWpGaD
Naratriptan—HTR1B—Signaling Pathways—GNB3—type 2 diabetes mellitus	2.22e-05	0.000168	CbGpPWpGaD
Naratriptan—HTR1D—Signaling Pathways—CDKN2B—type 2 diabetes mellitus	2.21e-05	0.000168	CbGpPWpGaD
Naratriptan—MAOA—Metabolism—GSTM1—type 2 diabetes mellitus	2.2e-05	0.000167	CbGpPWpGaD
Naratriptan—HTR1A—Signaling Pathways—EDNRA—type 2 diabetes mellitus	2.2e-05	0.000167	CbGpPWpGaD
Naratriptan—HTR1D—Signaling by GPCR—PIK3R1—type 2 diabetes mellitus	2.19e-05	0.000166	CbGpPWpGaD
Naratriptan—HTR1A—Signaling by GPCR—CALM1—type 2 diabetes mellitus	2.19e-05	0.000166	CbGpPWpGaD
Naratriptan—HTR1A—Signaling Pathways—CYBA—type 2 diabetes mellitus	2.19e-05	0.000166	CbGpPWpGaD
Naratriptan—HTR1B—Signaling Pathways—AVP—type 2 diabetes mellitus	2.19e-05	0.000166	CbGpPWpGaD
Naratriptan—HTR1B—Signaling Pathways—MMP3—type 2 diabetes mellitus	2.19e-05	0.000166	CbGpPWpGaD
Naratriptan—HTR1B—Signaling Pathways—IGF2—type 2 diabetes mellitus	2.18e-05	0.000165	CbGpPWpGaD
Naratriptan—HTR1B—Signaling Pathways—CDKN2B—type 2 diabetes mellitus	2.17e-05	0.000164	CbGpPWpGaD
Naratriptan—MAOA—Metabolism—LPL—type 2 diabetes mellitus	2.16e-05	0.000164	CbGpPWpGaD
Naratriptan—HTR1D—Signaling Pathways—APOB—type 2 diabetes mellitus	2.16e-05	0.000164	CbGpPWpGaD
Naratriptan—HTR1A—Signaling Pathways—ADRA2A—type 2 diabetes mellitus	2.15e-05	0.000163	CbGpPWpGaD
Naratriptan—HTR1D—Signaling Pathways—IGF1R—type 2 diabetes mellitus	2.15e-05	0.000163	CbGpPWpGaD
Naratriptan—HTR1B—Signaling by GPCR—PIK3R1—type 2 diabetes mellitus	2.15e-05	0.000163	CbGpPWpGaD
Naratriptan—HTR1A—Signaling Pathways—GHRL—type 2 diabetes mellitus	2.14e-05	0.000162	CbGpPWpGaD
Naratriptan—HTR1A—Signaling Pathways—PLAT—type 2 diabetes mellitus	2.14e-05	0.000162	CbGpPWpGaD
Naratriptan—HTR1D—Signaling Pathways—EDN1—type 2 diabetes mellitus	2.12e-05	0.000161	CbGpPWpGaD
Naratriptan—HTR1F—Signaling Pathways—SERPINE1—type 2 diabetes mellitus	2.12e-05	0.000161	CbGpPWpGaD
Naratriptan—MAOA—Metabolism—ADCY5—type 2 diabetes mellitus	2.12e-05	0.00016	CbGpPWpGaD
Naratriptan—HTR1A—Signaling Pathways—CALCA—type 2 diabetes mellitus	2.12e-05	0.00016	CbGpPWpGaD
Naratriptan—HTR1B—Signaling Pathways—APOB—type 2 diabetes mellitus	2.11e-05	0.00016	CbGpPWpGaD
Naratriptan—MAOA—Metabolism—GPX1—type 2 diabetes mellitus	2.11e-05	0.00016	CbGpPWpGaD
Naratriptan—HTR1B—Signaling Pathways—IGF1R—type 2 diabetes mellitus	2.1e-05	0.000159	CbGpPWpGaD
Naratriptan—HTR1B—Signaling Pathways—EDN1—type 2 diabetes mellitus	2.08e-05	0.000158	CbGpPWpGaD
Naratriptan—HTR1D—Signaling Pathways—LPL—type 2 diabetes mellitus	2.06e-05	0.000156	CbGpPWpGaD
Naratriptan—HTR1A—Signaling by GPCR—PRKCB—type 2 diabetes mellitus	2.06e-05	0.000156	CbGpPWpGaD
Naratriptan—MAOA—Metabolism—CD36—type 2 diabetes mellitus	2.05e-05	0.000156	CbGpPWpGaD
Naratriptan—MAOA—Metabolism—PPP2CA—type 2 diabetes mellitus	2.03e-05	0.000154	CbGpPWpGaD
Naratriptan—HTR1F—Signaling Pathways—PIK3R1—type 2 diabetes mellitus	2.02e-05	0.000153	CbGpPWpGaD
Naratriptan—HTR1F—Signaling Pathways—NOS3—type 2 diabetes mellitus	2.02e-05	0.000153	CbGpPWpGaD
Naratriptan—HTR1B—Signaling Pathways—LPL—type 2 diabetes mellitus	2.02e-05	0.000153	CbGpPWpGaD
Naratriptan—HTR1D—Signaling Pathways—ADCY5—type 2 diabetes mellitus	2.02e-05	0.000153	CbGpPWpGaD
Naratriptan—HTR1A—Signaling Pathways—TCF7L2—type 2 diabetes mellitus	1.99e-05	0.000151	CbGpPWpGaD
Naratriptan—HTR1A—GPCR downstream signaling—AKT2—type 2 diabetes mellitus	1.98e-05	0.00015	CbGpPWpGaD
Naratriptan—HTR1B—Signaling Pathways—ADCY5—type 2 diabetes mellitus	1.98e-05	0.00015	CbGpPWpGaD
Naratriptan—HTR1A—Signaling Pathways—GCG—type 2 diabetes mellitus	1.96e-05	0.000148	CbGpPWpGaD
Naratriptan—HTR1A—Signaling Pathways—PTPN1—type 2 diabetes mellitus	1.96e-05	0.000148	CbGpPWpGaD
Naratriptan—MAOA—Metabolism—MTHFR—type 2 diabetes mellitus	1.95e-05	0.000148	CbGpPWpGaD
Naratriptan—HTR1D—Signaling Pathways—PPP2CA—type 2 diabetes mellitus	1.93e-05	0.000146	CbGpPWpGaD
Naratriptan—HTR1A—Signaling Pathways—RASGRP1—type 2 diabetes mellitus	1.93e-05	0.000146	CbGpPWpGaD
Naratriptan—HTR1A—Signaling Pathways—NOTCH2—type 2 diabetes mellitus	1.92e-05	0.000146	CbGpPWpGaD
Naratriptan—MAOA—Metabolism—PPARA—type 2 diabetes mellitus	1.91e-05	0.000145	CbGpPWpGaD
Naratriptan—HTR1F—Signaling Pathways—RELA—type 2 diabetes mellitus	1.9e-05	0.000144	CbGpPWpGaD
Naratriptan—HTR1D—Signaling Pathways—CCR5—type 2 diabetes mellitus	1.9e-05	0.000144	CbGpPWpGaD
Naratriptan—HTR1B—Signaling Pathways—PPP2CA—type 2 diabetes mellitus	1.89e-05	0.000143	CbGpPWpGaD
Naratriptan—HTR1B—Signaling Pathways—CCR5—type 2 diabetes mellitus	1.86e-05	0.000141	CbGpPWpGaD
Naratriptan—HTR1D—Signaling Pathways—C3—type 2 diabetes mellitus	1.86e-05	0.000141	CbGpPWpGaD
Naratriptan—MAOA—Metabolism—AGT—type 2 diabetes mellitus	1.85e-05	0.00014	CbGpPWpGaD
Naratriptan—HTR1A—Signaling by GPCR—CCL2—type 2 diabetes mellitus	1.83e-05	0.000139	CbGpPWpGaD
Naratriptan—MAOA—Metabolism—CALM1—type 2 diabetes mellitus	1.82e-05	0.000138	CbGpPWpGaD
Naratriptan—HTR1B—Signaling Pathways—C3—type 2 diabetes mellitus	1.82e-05	0.000138	CbGpPWpGaD
Naratriptan—MAOA—Metabolism—APOE—type 2 diabetes mellitus	1.81e-05	0.000137	CbGpPWpGaD
Naratriptan—HTR1A—Signaling by GPCR—AKT2—type 2 diabetes mellitus	1.8e-05	0.000136	CbGpPWpGaD
Naratriptan—HTR1A—GPCR downstream signaling—PIK3R1—type 2 diabetes mellitus	1.8e-05	0.000136	CbGpPWpGaD
Naratriptan—MAOA—Metabolism—APOA1—type 2 diabetes mellitus	1.79e-05	0.000136	CbGpPWpGaD
Naratriptan—HTR1D—Signaling Pathways—HIF1A—type 2 diabetes mellitus	1.77e-05	0.000134	CbGpPWpGaD
Naratriptan—HTR1D—Signaling Pathways—IRS2—type 2 diabetes mellitus	1.77e-05	0.000134	CbGpPWpGaD
Naratriptan—HTR1D—Signaling Pathways—AGT—type 2 diabetes mellitus	1.76e-05	0.000134	CbGpPWpGaD
Naratriptan—HTR1F—GPCR downstream signaling—AKT1—type 2 diabetes mellitus	1.73e-05	0.000131	CbGpPWpGaD
Naratriptan—HTR1D—Signaling Pathways—CALM1—type 2 diabetes mellitus	1.73e-05	0.000131	CbGpPWpGaD
Naratriptan—HTR1B—Signaling Pathways—HIF1A—type 2 diabetes mellitus	1.73e-05	0.000131	CbGpPWpGaD
Naratriptan—HTR1B—Signaling Pathways—IRS2—type 2 diabetes mellitus	1.73e-05	0.000131	CbGpPWpGaD
Naratriptan—HTR1D—Signaling Pathways—APOE—type 2 diabetes mellitus	1.73e-05	0.000131	CbGpPWpGaD
Naratriptan—HTR1D—Signaling Pathways—LEP—type 2 diabetes mellitus	1.73e-05	0.000131	CbGpPWpGaD
Naratriptan—HTR1B—Signaling Pathways—AGT—type 2 diabetes mellitus	1.73e-05	0.000131	CbGpPWpGaD
Naratriptan—HTR1F—Signaling Pathways—CASP3—type 2 diabetes mellitus	1.72e-05	0.00013	CbGpPWpGaD
Naratriptan—HTR1D—Signaling Pathways—APOA1—type 2 diabetes mellitus	1.71e-05	0.000129	CbGpPWpGaD
Naratriptan—HTR1F—Signaling by GPCR—IL6—type 2 diabetes mellitus	1.71e-05	0.000129	CbGpPWpGaD
Naratriptan—HTR1A—Signaling Pathways—TGFBR2—type 2 diabetes mellitus	1.7e-05	0.000129	CbGpPWpGaD
Naratriptan—HTR1B—Signaling Pathways—CALM1—type 2 diabetes mellitus	1.7e-05	0.000129	CbGpPWpGaD
Naratriptan—HTR1B—Signaling Pathways—LEP—type 2 diabetes mellitus	1.69e-05	0.000128	CbGpPWpGaD
Naratriptan—HTR1B—Signaling Pathways—APOE—type 2 diabetes mellitus	1.69e-05	0.000128	CbGpPWpGaD
Naratriptan—HTR1A—Signaling Pathways—GNB3—type 2 diabetes mellitus	1.69e-05	0.000128	CbGpPWpGaD
Naratriptan—HTR1B—Signaling Pathways—APOA1—type 2 diabetes mellitus	1.67e-05	0.000127	CbGpPWpGaD
Naratriptan—HTR1A—Signaling Pathways—AVP—type 2 diabetes mellitus	1.67e-05	0.000126	CbGpPWpGaD
Naratriptan—HTR1A—Signaling Pathways—MMP3—type 2 diabetes mellitus	1.67e-05	0.000126	CbGpPWpGaD
Naratriptan—HTR1A—Signaling Pathways—IGF2—type 2 diabetes mellitus	1.66e-05	0.000126	CbGpPWpGaD
Naratriptan—HTR1A—Signaling Pathways—CDKN2B—type 2 diabetes mellitus	1.65e-05	0.000125	CbGpPWpGaD
Naratriptan—HTR1A—Signaling by GPCR—PIK3R1—type 2 diabetes mellitus	1.63e-05	0.000124	CbGpPWpGaD
Naratriptan—HTR1D—Signaling Pathways—PRKCB—type 2 diabetes mellitus	1.63e-05	0.000123	CbGpPWpGaD
Naratriptan—HTR1F—Signaling Pathways—MMP9—type 2 diabetes mellitus	1.62e-05	0.000123	CbGpPWpGaD
Naratriptan—HTR1A—Signaling Pathways—APOB—type 2 diabetes mellitus	1.61e-05	0.000122	CbGpPWpGaD
Naratriptan—HTR1F—Signaling Pathways—NFKB1—type 2 diabetes mellitus	1.61e-05	0.000122	CbGpPWpGaD
Naratriptan—HTR1A—Signaling Pathways—IGF1R—type 2 diabetes mellitus	1.6e-05	0.000121	CbGpPWpGaD
Naratriptan—HTR1B—Signaling Pathways—PRKCB—type 2 diabetes mellitus	1.6e-05	0.000121	CbGpPWpGaD
Naratriptan—HTR1A—Signaling Pathways—EDN1—type 2 diabetes mellitus	1.58e-05	0.00012	CbGpPWpGaD
Naratriptan—MAOA—Metabolism—PPARG—type 2 diabetes mellitus	1.58e-05	0.00012	CbGpPWpGaD
Naratriptan—HTR1F—Signaling by GPCR—AKT1—type 2 diabetes mellitus	1.57e-05	0.000119	CbGpPWpGaD
Naratriptan—MAOA—Metabolism—INS—type 2 diabetes mellitus	1.55e-05	0.000117	CbGpPWpGaD
Naratriptan—HTR1D—Signaling Pathways—IRS1—type 2 diabetes mellitus	1.54e-05	0.000117	CbGpPWpGaD
Naratriptan—HTR1A—Signaling Pathways—LPL—type 2 diabetes mellitus	1.54e-05	0.000116	CbGpPWpGaD
Naratriptan—HTR1B—Signaling Pathways—IRS1—type 2 diabetes mellitus	1.51e-05	0.000114	CbGpPWpGaD
Naratriptan—HTR1A—Signaling Pathways—ADCY5—type 2 diabetes mellitus	1.5e-05	0.000114	CbGpPWpGaD
Naratriptan—HTR1F—Signaling Pathways—SRC—type 2 diabetes mellitus	1.5e-05	0.000113	CbGpPWpGaD
Naratriptan—HTR1D—Signaling Pathways—INS—type 2 diabetes mellitus	1.48e-05	0.000112	CbGpPWpGaD
Naratriptan—HTR1F—Signaling Pathways—VEGFA—type 2 diabetes mellitus	1.46e-05	0.00011	CbGpPWpGaD
Naratriptan—HTR1D—Signaling Pathways—CCL2—type 2 diabetes mellitus	1.45e-05	0.00011	CbGpPWpGaD
Naratriptan—HTR1B—Signaling Pathways—INS—type 2 diabetes mellitus	1.45e-05	0.000109	CbGpPWpGaD
Naratriptan—HTR1A—Signaling Pathways—PPP2CA—type 2 diabetes mellitus	1.44e-05	0.000109	CbGpPWpGaD
Naratriptan—HTR1D—Signaling Pathways—IGF1—type 2 diabetes mellitus	1.43e-05	0.000108	CbGpPWpGaD
Naratriptan—HTR1D—Signaling Pathways—AKT2—type 2 diabetes mellitus	1.43e-05	0.000108	CbGpPWpGaD
Naratriptan—HTR1B—Signaling Pathways—CCL2—type 2 diabetes mellitus	1.42e-05	0.000108	CbGpPWpGaD
Naratriptan—HTR1D—Signaling by GPCR—EGFR—type 2 diabetes mellitus	1.42e-05	0.000108	CbGpPWpGaD
Naratriptan—MAOA—Metabolism—ALB—type 2 diabetes mellitus	1.42e-05	0.000108	CbGpPWpGaD
Naratriptan—HTR1A—Signaling Pathways—CCR5—type 2 diabetes mellitus	1.42e-05	0.000107	CbGpPWpGaD
Naratriptan—HTR1B—Signaling Pathways—IGF1—type 2 diabetes mellitus	1.4e-05	0.000106	CbGpPWpGaD
Naratriptan—HTR1B—Signaling Pathways—AKT2—type 2 diabetes mellitus	1.4e-05	0.000106	CbGpPWpGaD
Naratriptan—HTR1B—Signaling by GPCR—EGFR—type 2 diabetes mellitus	1.39e-05	0.000105	CbGpPWpGaD
Naratriptan—HTR1A—Signaling Pathways—C3—type 2 diabetes mellitus	1.38e-05	0.000105	CbGpPWpGaD
Naratriptan—MAOA—Metabolism—PIK3R1—type 2 diabetes mellitus	1.36e-05	0.000103	CbGpPWpGaD
Naratriptan—MAOA—Metabolism—NOS3—type 2 diabetes mellitus	1.36e-05	0.000103	CbGpPWpGaD
Naratriptan—HTR1D—Signaling Pathways—SERPINE1—type 2 diabetes mellitus	1.36e-05	0.000103	CbGpPWpGaD
Naratriptan—HTR1F—Signaling Pathways—TGFB1—type 2 diabetes mellitus	1.34e-05	0.000101	CbGpPWpGaD
Naratriptan—HTR1B—Signaling Pathways—SERPINE1—type 2 diabetes mellitus	1.33e-05	0.000101	CbGpPWpGaD
Naratriptan—HTR1A—Signaling Pathways—HIF1A—type 2 diabetes mellitus	1.32e-05	0.0001	CbGpPWpGaD
Naratriptan—HTR1A—Signaling Pathways—IRS2—type 2 diabetes mellitus	1.32e-05	9.98e-05	CbGpPWpGaD
Naratriptan—HTR1A—Signaling Pathways—AGT—type 2 diabetes mellitus	1.32e-05	9.96e-05	CbGpPWpGaD
Naratriptan—HTR1F—Signaling Pathways—EGFR—type 2 diabetes mellitus	1.31e-05	9.94e-05	CbGpPWpGaD
Naratriptan—HTR1D—Signaling Pathways—PIK3R1—type 2 diabetes mellitus	1.29e-05	9.8e-05	CbGpPWpGaD
Naratriptan—HTR1D—Signaling Pathways—NOS3—type 2 diabetes mellitus	1.29e-05	9.8e-05	CbGpPWpGaD
Naratriptan—HTR1A—Signaling Pathways—CALM1—type 2 diabetes mellitus	1.29e-05	9.8e-05	CbGpPWpGaD
Naratriptan—HTR1A—Signaling Pathways—APOE—type 2 diabetes mellitus	1.29e-05	9.76e-05	CbGpPWpGaD
Naratriptan—HTR1A—Signaling Pathways—LEP—type 2 diabetes mellitus	1.29e-05	9.76e-05	CbGpPWpGaD
Naratriptan—HTR1A—Signaling Pathways—APOA1—type 2 diabetes mellitus	1.27e-05	9.65e-05	CbGpPWpGaD
Naratriptan—HTR1B—Signaling Pathways—NOS3—type 2 diabetes mellitus	1.27e-05	9.6e-05	CbGpPWpGaD
Naratriptan—HTR1B—Signaling Pathways—PIK3R1—type 2 diabetes mellitus	1.27e-05	9.6e-05	CbGpPWpGaD
Naratriptan—MAOA—Metabolism—PTGS2—type 2 diabetes mellitus	1.24e-05	9.41e-05	CbGpPWpGaD
Naratriptan—HTR1D—Signaling Pathways—RELA—type 2 diabetes mellitus	1.22e-05	9.23e-05	CbGpPWpGaD
Naratriptan—HTR1A—Signaling Pathways—PRKCB—type 2 diabetes mellitus	1.22e-05	9.21e-05	CbGpPWpGaD
Naratriptan—HTR1B—Signaling Pathways—RELA—type 2 diabetes mellitus	1.19e-05	9.04e-05	CbGpPWpGaD
Naratriptan—HTR1A—Signaling Pathways—IRS1—type 2 diabetes mellitus	1.15e-05	8.71e-05	CbGpPWpGaD
Naratriptan—HTR1D—GPCR downstream signaling—AKT1—type 2 diabetes mellitus	1.11e-05	8.4e-05	CbGpPWpGaD
Naratriptan—HTR1A—Signaling Pathways—INS—type 2 diabetes mellitus	1.1e-05	8.34e-05	CbGpPWpGaD
Naratriptan—HTR1D—Signaling Pathways—CASP3—type 2 diabetes mellitus	1.1e-05	8.32e-05	CbGpPWpGaD
Naratriptan—HTR1D—Signaling by GPCR—IL6—type 2 diabetes mellitus	1.09e-05	8.27e-05	CbGpPWpGaD
Naratriptan—HTR1B—GPCR downstream signaling—AKT1—type 2 diabetes mellitus	1.09e-05	8.23e-05	CbGpPWpGaD
Naratriptan—HTR1A—Signaling Pathways—CCL2—type 2 diabetes mellitus	1.08e-05	8.2e-05	CbGpPWpGaD
Naratriptan—HTR1B—Signaling Pathways—CASP3—type 2 diabetes mellitus	1.08e-05	8.15e-05	CbGpPWpGaD
Naratriptan—HTR1B—Signaling by GPCR—IL6—type 2 diabetes mellitus	1.07e-05	8.1e-05	CbGpPWpGaD
Naratriptan—HTR1A—Signaling Pathways—IGF1—type 2 diabetes mellitus	1.06e-05	8.07e-05	CbGpPWpGaD
Naratriptan—HTR1A—Signaling Pathways—AKT2—type 2 diabetes mellitus	1.06e-05	8.06e-05	CbGpPWpGaD
Naratriptan—HTR1A—Signaling by GPCR—EGFR—type 2 diabetes mellitus	1.06e-05	8.03e-05	CbGpPWpGaD
Naratriptan—HTR1D—Signaling Pathways—MMP9—type 2 diabetes mellitus	1.04e-05	7.87e-05	CbGpPWpGaD
Naratriptan—HTR1D—Signaling Pathways—NFKB1—type 2 diabetes mellitus	1.03e-05	7.78e-05	CbGpPWpGaD
Naratriptan—HTR1B—Signaling Pathways—MMP9—type 2 diabetes mellitus	1.02e-05	7.7e-05	CbGpPWpGaD
Naratriptan—HTR1A—Signaling Pathways—SERPINE1—type 2 diabetes mellitus	1.01e-05	7.66e-05	CbGpPWpGaD
Naratriptan—HTR1F—Signaling Pathways—IL6—type 2 diabetes mellitus	1.01e-05	7.64e-05	CbGpPWpGaD
Naratriptan—HTR1D—Signaling by GPCR—AKT1—type 2 diabetes mellitus	1.01e-05	7.63e-05	CbGpPWpGaD
Naratriptan—HTR1B—Signaling Pathways—NFKB1—type 2 diabetes mellitus	1.01e-05	7.62e-05	CbGpPWpGaD
Naratriptan—HTR1B—Signaling by GPCR—AKT1—type 2 diabetes mellitus	9.86e-06	7.47e-05	CbGpPWpGaD
Naratriptan—HTR1A—Signaling Pathways—NOS3—type 2 diabetes mellitus	9.65e-06	7.31e-05	CbGpPWpGaD
Naratriptan—HTR1A—Signaling Pathways—PIK3R1—type 2 diabetes mellitus	9.65e-06	7.31e-05	CbGpPWpGaD
Naratriptan—HTR1D—Signaling Pathways—SRC—type 2 diabetes mellitus	9.57e-06	7.25e-05	CbGpPWpGaD
Naratriptan—HTR1B—Signaling Pathways—SRC—type 2 diabetes mellitus	9.37e-06	7.1e-05	CbGpPWpGaD
Naratriptan—HTR1D—Signaling Pathways—VEGFA—type 2 diabetes mellitus	9.32e-06	7.06e-05	CbGpPWpGaD
Naratriptan—HTR1F—Signaling Pathways—AKT1—type 2 diabetes mellitus	9.3e-06	7.05e-05	CbGpPWpGaD
Naratriptan—HTR1B—Signaling Pathways—VEGFA—type 2 diabetes mellitus	9.13e-06	6.92e-05	CbGpPWpGaD
Naratriptan—HTR1A—Signaling Pathways—RELA—type 2 diabetes mellitus	9.09e-06	6.88e-05	CbGpPWpGaD
Naratriptan—HTR1D—Signaling Pathways—TGFB1—type 2 diabetes mellitus	8.56e-06	6.48e-05	CbGpPWpGaD
Naratriptan—HTR1D—Signaling Pathways—EGFR—type 2 diabetes mellitus	8.39e-06	6.36e-05	CbGpPWpGaD
Naratriptan—HTR1B—Signaling Pathways—TGFB1—type 2 diabetes mellitus	8.38e-06	6.35e-05	CbGpPWpGaD
Naratriptan—HTR1A—GPCR downstream signaling—AKT1—type 2 diabetes mellitus	8.27e-06	6.27e-05	CbGpPWpGaD
Naratriptan—HTR1B—Signaling Pathways—EGFR—type 2 diabetes mellitus	8.22e-06	6.22e-05	CbGpPWpGaD
Naratriptan—HTR1A—Signaling Pathways—CASP3—type 2 diabetes mellitus	8.2e-06	6.21e-05	CbGpPWpGaD
Naratriptan—HTR1A—Signaling by GPCR—IL6—type 2 diabetes mellitus	8.14e-06	6.17e-05	CbGpPWpGaD
Naratriptan—HTR1A—Signaling Pathways—MMP9—type 2 diabetes mellitus	7.75e-06	5.87e-05	CbGpPWpGaD
Naratriptan—HTR1A—Signaling Pathways—NFKB1—type 2 diabetes mellitus	7.66e-06	5.81e-05	CbGpPWpGaD
Naratriptan—HTR1A—Signaling by GPCR—AKT1—type 2 diabetes mellitus	7.51e-06	5.69e-05	CbGpPWpGaD
Naratriptan—HTR1A—Signaling Pathways—SRC—type 2 diabetes mellitus	7.14e-06	5.41e-05	CbGpPWpGaD
Naratriptan—HTR1A—Signaling Pathways—VEGFA—type 2 diabetes mellitus	6.95e-06	5.27e-05	CbGpPWpGaD
Naratriptan—HTR1D—Signaling Pathways—IL6—type 2 diabetes mellitus	6.45e-06	4.89e-05	CbGpPWpGaD
Naratriptan—HTR1A—Signaling Pathways—TGFB1—type 2 diabetes mellitus	6.38e-06	4.84e-05	CbGpPWpGaD
Naratriptan—HTR1B—Signaling Pathways—IL6—type 2 diabetes mellitus	6.31e-06	4.78e-05	CbGpPWpGaD
Naratriptan—HTR1A—Signaling Pathways—EGFR—type 2 diabetes mellitus	6.26e-06	4.74e-05	CbGpPWpGaD
Naratriptan—MAOA—Metabolism—AKT1—type 2 diabetes mellitus	6.24e-06	4.73e-05	CbGpPWpGaD
Naratriptan—HTR1D—Signaling Pathways—AKT1—type 2 diabetes mellitus	5.95e-06	4.51e-05	CbGpPWpGaD
Naratriptan—HTR1B—Signaling Pathways—AKT1—type 2 diabetes mellitus	5.83e-06	4.41e-05	CbGpPWpGaD
Naratriptan—HTR1A—Signaling Pathways—IL6—type 2 diabetes mellitus	4.81e-06	3.64e-05	CbGpPWpGaD
Naratriptan—HTR1A—Signaling Pathways—AKT1—type 2 diabetes mellitus	4.44e-06	3.36e-05	CbGpPWpGaD
